"Especially to have someone there realize that we
Post# of 148112
Yes, to have the FDA understand that Leronlimab is an immune system modulator, not an immune suppressor, and not a check point inhibitor. I hope our new management is very clear about the mechanism of action, when they develop the protocol for the next clinical.
Read More: https://investorshangout.com/post/view?id=651...z7pOQJ3zKc